Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease

Overview of attention for article published in Frontiers in Neuroscience, December 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 2 news outlets
twitter: 12 X users

facebook: 2 Facebook pages

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 71 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease.

Alzforum, 08 Jan 2021

. Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease.

Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer’s and Parkinson’s Disease

MyNeuroNews, 14 Dec 2020

Much thought has been given to the impact of Amyloid Beta, Tau and Alpha-Synuclein in the development of Alzheimer’s disease (AD…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.